SCHEMBL7685244

SCHEMBL7685244

CCCOC(=O)C1=C(C)NC(c2ccccc2)=C(C(=O)OCC)C1C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 13/20 0.67
TMIGD3 P0DMS9 2/20 0.59
TRPV1 Q8NER1 3/20 0.58
KDM4E B2RXH2 2/20 0.57
LMNA P02545 1/20 0.57
ALDH1A1 P00352 3/20 0.57
MAPT P10636 2/20 0.52
RECQL P46063 2/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
CYP2C19 P33261 1/20 0.52
HSD17B10 Q99714 1/20 0.52
TDP1 Q9NUW8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7687629 0.93 ADORA3 (0.75) ADORA3TMIGD3TRPV1KDM4ELMNA
SCHEMBL7680777 0.80 ADORA3 (1.00) ADORA3TMIGD3TRPV1ALDH1A1CACNA1D
SCHEMBL7689604 0.80 ADORA3 (0.65) ADORA3TMIGD3TRPV1KDM4ELMNA
SCHEMBL1664685 0.79 ADORA3 (0.71) ADORA3TMIGD3TRPV1KDM4ELMNA
SCHEMBL7383408 0.79 ALDH1A1 (0.57) ADORA3TMIGD3TRPV1KDM4EALDH1A1
SCHEMBL7383409 0.79 ALDH1A1 (0.57) ADORA3TMIGD3TRPV1KDM4EALDH1A1
SCHEMBL7685108 0.78 ADORA3 (0.74) ADORA3TMIGD3TRPV1KDM4EALDH1A1
SCHEMBL12648462 0.77 ALDH1A1 (0.84) ADORA3TRPV1KDM4ELMNAALDH1A1
SCHEMBL7687307 0.76 ADORA3 (1.00) ADORA3TMIGD3TRPV1ALDH1A1CACNA1D
SCHEMBL8327248 0.76 ADORA3 (0.68) ADORA3TMIGD3TRPV1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376521-B1 ANTIINFLAMMATORY AGENTS; ANTIISCHEMIC AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2002-04-23 US disclosed
WO-2000002861-A1 A3 ADENOSINE RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-01-20 WO disclosed